Lv31
250 积分 2021-07-26 加入
Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review
1小时前
待确认
A renaissance for YES in cancer
2个月前
已完结
YES1: A Novel Therapeutic Target and Biomarker in Cancer
2个月前
已完结
Elucidating the potential effects of point mutations on FGFR3 inhibitor resistance via combined molecular dynamics simulation and community network analysis
4个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
4个月前
已完结
Research Progress in Targeting GSPT1: Molecular Glues, Bifunctional Degraders, and Antibody-Enabled Molecular Glues for Cancer Therapy
4个月前
已完结
Infigratinib low dose therapy is an effective strategy to treat hypochondroplasia
4个月前
已完结
Discovery of Pyrrolopyrazine Carboxamide Derivatives as Potent and Selective FGFR2/3 Inhibitors that Overcome Mutant Resistance
5个月前
已完结
Biomarkers for Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced/Metastatic Breast Cancer: Translation to Clinical Practice
6个月前
已完结
Discovery of Novel PROTAC-Based HPK1 Degraders with High Potency and Selectivity for Cancer Immunotherapy
6个月前
已完结
皖公网安备34019202002308
